On the eve of a Philadelphia Risperdal trial, Johnson & Johnson and Janssen Pharmaceuticals Inc. agreed to settle a lawsuit alleging a New York boy grew female breasts after...
The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end...
Just weeks after healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals reached a confidential settlement with a Risperdal plaintiff, the companies are going to trial in...
The fifth Risperdal case to go to trial was a game changer for Janssen Pharmaceuticals and its parent company, Johnson & Johnson (J&J). The companies previously escaped large payouts...
When Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals received FDA approval for their antipsychotic Risperdal in 1993, the companies anticipated the drug would be a blockbuster hit....
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals were likely shocked by the $70 million plaintiff’s verdict after the fifth Risperdal trial this past July. The...
For thousands of Risperdal lawsuits pending in Philadelphia, a judges ruling could see their cases dismissed. A Pennsylvania appeals court has heard arguments from both sides regarding when the...
Before Johnson & Johnson (J&J) became a publicly traded company in 1943, the company’s chairman and member of the founding family, Robert Wood Johnson, created the company’s credo. Considered...
One of the strongest pieces of evidence presented in the Risperdal trials is a video deposition of former FDA Commissioner David Kessler testifying that Janssen and J&J manipulated clinical...
When a Philadelphia judge awarded a Tennessee man and his family $70 million in damages because of Risperdal side effects this past July, it sent shockwaves through the Risperdal...
